Xing RW, Nie HQ, Zhou XF, Zhang FF, Mou YH. Left abdominal wall proliferative myositis resection and patch repair: A case report. World J Clin Cases 2022; 10(6): 1922-1928 [PMID: 35317138 DOI: 10.12998/wjcc.v10.i6.1922]
Corresponding Author of This Article
Yong-Hua Mou, MD, Doctor, Surgeon, Department of Hepatobiliary Surgery, Taizhou Municipal Hospital, No. 381 Zhongshan East Road, Jiaojiang District, Taizhou 318000, Zhejiang Province, China. mouyh2000@163.com
Research Domain of This Article
Oncology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Feb 26, 2022; 10(6): 1922-1928 Published online Feb 26, 2022. doi: 10.12998/wjcc.v10.i6.1922
Left abdominal wall proliferative myositis resection and patch repair: A case report
Ren-Wei Xing, Han-Qiu Nie, Xian-Fei Zhou, Fang-Fang Zhang, Yong-Hua Mou
Ren-Wei Xing, Han-Qiu Nie, Xian-Fei Zhou, Yong-Hua Mou, Department of Hepatobiliary Surgery, Taizhou Municipal Hospital, Taizhou 318000, Zhejiang Province, China
Fang-Fang Zhang, Department of Pathology, Taizhou Municipal Hospital, Taizhou 318000, Zhejiang Province, China
Author contributions: Xing RW chaired the surgery and wrote the manuscript; Nie HQ guided the surgery; Zhou XF collected the data and collated the graphs; Zhang FF provided and discussed the pathological findings; Mou YH contributed to the discussion and revision; all authors gave final approval of the submitted version for publication.
Supported byYonghua Mou’s Famous Doctor Studio, No. 2020-42.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yong-Hua Mou, MD, Doctor, Surgeon, Department of Hepatobiliary Surgery, Taizhou Municipal Hospital, No. 381 Zhongshan East Road, Jiaojiang District, Taizhou 318000, Zhejiang Province, China. mouyh2000@163.com
Received: August 4, 2021 Peer-review started: August 4, 2021 First decision: November 6, 2021 Revised: November 20, 2021 Accepted: January 19, 2022 Article in press: January 19, 2022 Published online: February 26, 2022 Processing time: 203 Days and 1.4 Hours
Abstract
BACKGROUND
Proliferative myositis is a rare benign tumor that is typically self-limiting and does not become malignant. It can be cured by simple resection without reported recurrence. Due to its rapid growth, hard structure and ill-defined borders, it can however be mistaken for malignant tumors such as sarcomas.
CASE SUMMARY
We investigate the case of a 64-year-old male with proliferative myositis of the abdominal wall, who was preoperatively administered a needle aspiration biopsy and given a simple excision and patch repair. We then compared it with other similar cases to determine the effectiveness of this treatment method.
CONCLUSION
Resection with follow-up observation has shown to be an effective treatment method for proliferative myositis. To avoid unnecessarily extended or destructive resection, a thorough and conclusive diagnosis is crucial, which requires adequate imaging and pathological knowledge.
Core Tip: Proliferative myositis is a rare and self-limiting benign tumor. Although preoperative imaging can identify certain characteristics, it is still difficult to achieve a conclusive diagnosis. Most cases are not diagnosed until after surgical resection. A needle biopsy is helpful in the diagnosis of proliferative myositis, and surgery involving local excision is sufficient. When the resected mass is located in the abdominal wall, local defects can be considered for patch repair. The key to treatment lies in avoiding misdiagnosis as a malignant tumor, resulting in excessive extended resection and corresponding trauma.
